Table of Contents Executive Summary 1 Industry Overview of Parkinsons Disease Drugs 1.1 Definition of Parkinsons Disease Drugs 1.2 Parkinsons Disease Drugs Segment by Type 1.2.1 Global Parkinsons Disease Drugs Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Clinical 1.2.3 Experiment 1.3 Parkinsons Disease Drugs Segment by Applications 1.3.1 Global Parkinsons Disease Drugs Consumption Comparison by Applications (2014-2025) 1.3.2 Treament 1.3.3 Prevention 1.4 Global Parkinsons Disease Drugs Overall Market 1.4.1 Global Parkinsons Disease Drugs Revenue (2014-2025) 1.4.2 Global Parkinsons Disease Drugs Production (2014-2025) 1.4.3 North America Parkinsons Disease Drugs Status and Prospect (2014-2025) 1.4.4 Europe Parkinsons Disease Drugs Status and Prospect (2014-2025) 1.4.5 China Parkinsons Disease Drugs Status and Prospect (2014-2025) 1.4.6 Japan Parkinsons Disease Drugs Status and Prospect (2014-2025) 1.4.7 Southeast Asia Parkinsons Disease Drugs Status and Prospect (2014-2025) 1.4.8 India Parkinsons Disease Drugs Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Parkinsons Disease Drugs 2.3 Manufacturing Process Analysis of Parkinsons Disease Drugs 2.4 Industry Chain Structure of Parkinsons Disease Drugs 3 Development and Manufacturing Plants Analysis of Parkinsons Disease Drugs 3.1 Capacity and Commercial Production Date 3.2 Global Parkinsons Disease Drugs Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Parkinsons Disease Drugs 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Parkinsons Disease Drugs Production and Capacity Analysis 4.2 Parkinsons Disease Drugs Revenue Analysis 4.3 Parkinsons Disease Drugs Price Analysis 4.4 Market Concentration Degree 5 Parkinsons Disease Drugs Regional Market Analysis 5.1 Parkinsons Disease Drugs Production by Regions 5.1.1 Global Parkinsons Disease Drugs Production by Regions 5.1.2 Global Parkinsons Disease Drugs Revenue by Regions 5.2 Parkinsons Disease Drugs Consumption by Regions 5.3 North America Parkinsons Disease Drugs Market Analysis 5.3.1 North America Parkinsons Disease Drugs Production 5.3.2 North America Parkinsons Disease Drugs Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Parkinsons Disease Drugs Import and Export 5.4 Europe Parkinsons Disease Drugs Market Analysis 5.4.1 Europe Parkinsons Disease Drugs Production 5.4.2 Europe Parkinsons Disease Drugs Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Parkinsons Disease Drugs Import and Export 5.5 China Parkinsons Disease Drugs Market Analysis 5.5.1 China Parkinsons Disease Drugs Production 5.5.2 China Parkinsons Disease Drugs Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Parkinsons Disease Drugs Import and Export 5.6 Japan Parkinsons Disease Drugs Market Analysis 5.6.1 Japan Parkinsons Disease Drugs Production 5.6.2 Japan Parkinsons Disease Drugs Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Parkinsons Disease Drugs Import and Export 5.7 Southeast Asia Parkinsons Disease Drugs Market Analysis 5.7.1 Southeast Asia Parkinsons Disease Drugs Production 5.7.2 Southeast Asia Parkinsons Disease Drugs Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Parkinsons Disease Drugs Import and Export 5.8 India Parkinsons Disease Drugs Market Analysis 5.8.1 India Parkinsons Disease Drugs Production 5.8.2 India Parkinsons Disease Drugs Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Parkinsons Disease Drugs Import and Export 6 Parkinsons Disease Drugs Segment Market Analysis (by Type) 6.1 Global Parkinsons Disease Drugs Production by Type 6.2 Global Parkinsons Disease Drugs Revenue by Type 6.3 Parkinsons Disease Drugs Price by Type 7 Parkinsons Disease Drugs Segment Market Analysis (by Application) 7.1 Global Parkinsons Disease Drugs Consumption by Application 7.2 Global Parkinsons Disease Drugs Consumption Market Share by Application (2014-2019) 8 Parkinsons Disease Drugs Major Manufacturers Analysis 8.1 Johnson & Johnson 8.1.1 Johnson & Johnson Parkinsons Disease Drugs Production Sites and Area Served 8.1.2 Johnson & Johnson Product Introduction, Application and Specification 8.1.3 Johnson & Johnson Parkinsons Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Gilead Sciences 8.2.1 Gilead Sciences Parkinsons Disease Drugs Production Sites and Area Served 8.2.2 Gilead Sciences Product Introduction, Application and Specification 8.2.3 Gilead Sciences Parkinsons Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Pacira 8.3.1 Pacira Parkinsons Disease Drugs Production Sites and Area Served 8.3.2 Pacira Product Introduction, Application and Specification 8.3.3 Pacira Parkinsons Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Sun Pharmaceutical 8.4.1 Sun Pharmaceutical Parkinsons Disease Drugs Production Sites and Area Served 8.4.2 Sun Pharmaceutical Product Introduction, Application and Specification 8.4.3 Sun Pharmaceutical Parkinsons Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Luye Pharma 8.5.1 Luye Pharma Parkinsons Disease Drugs Production Sites and Area Served 8.5.2 Luye Pharma Product Introduction, Application and Specification 8.5.3 Luye Pharma Parkinsons Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Sigma-Tau Group 8.6.1 Sigma-Tau Group Parkinsons Disease Drugs Production Sites and Area Served 8.6.2 Sigma-Tau Group Product Introduction, Application and Specification 8.6.3 Sigma-Tau Group Parkinsons Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 Fudan-Zhangjiang 8.7.1 Fudan-Zhangjiang Parkinsons Disease Drugs Production Sites and Area Served 8.7.2 Fudan-Zhangjiang Product Introduction, Application and Specification 8.7.3 Fudan-Zhangjiang Parkinsons Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 8.8 Teva Pharmaceutical 8.8.1 Teva Pharmaceutical Parkinsons Disease Drugs Production Sites and Area Served 8.8.2 Teva Pharmaceutical Product Introduction, Application and Specification 8.8.3 Teva Pharmaceutical Parkinsons Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.8.4 Main Business and Markets Served 8.9 CSPC 8.9.1 CSPC Parkinsons Disease Drugs Production Sites and Area Served 8.9.2 CSPC Product Introduction, Application and Specification 8.9.3 CSPC Parkinsons Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.9.4 Main Business and Markets Served 8.10 Novartis 8.10.1 Novartis Parkinsons Disease Drugs Production Sites and Area Served 8.10.2 Novartis Product Introduction, Application and Specification 8.10.3 Novartis Parkinsons Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.10.4 Main Business and Markets Served 8.11 Kingond Pharm 9 Development Trend of Analysis of Parkinsons Disease Drugs Market 9.1 Global Parkinsons Disease Drugs Market Trend Analysis 9.1.1 Global Parkinsons Disease Drugs Market Size (Volume and Value) Forecast 2019-2025 9.2 Parkinsons Disease Drugs Regional Market Trend 9.2.1 North America Parkinsons Disease Drugs Forecast 2019-2025 9.2.2 Europe Parkinsons Disease Drugs Forecast 2019-2025 9.2.3 China Parkinsons Disease Drugs Forecast 2019-2025 9.2.4 Japan Parkinsons Disease Drugs Forecast 2019-2025 9.2.5 Southeast Asia Parkinsons Disease Drugs Forecast 2019-2025 9.2.6 India Parkinsons Disease Drugs Forecast 2019-2025 9.3 Parkinsons Disease Drugs Market Trend (Product Type) 9.4 Parkinsons Disease Drugs Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Parkinsons Disease Drugs Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Parkinsons Disease Drugs Table Global Parkinsons Disease Drugs Production (Units) Growth Rate Comparison by Types (2014-2025) Figure Global Parkinsons Disease Drugs Production Market Share by Types in 2018 Figure Clinical Product Picture Figure Experiment Product Picture Table Global Parkinsons Disease Drugs Consumption (Units) Comparison by Applications (2014-2025) Figure Global Parkinsons Disease Drugs Consumption Market Share by Applications in 2018 Figure Treament Figure Prevention Figure Global Parkinsons Disease Drugs Revenue (Million USD) (2014-2025) Figure Global Parkinsons Disease Drugs Production (Units) (2014-2025) Figure North America Parkinsons Disease Drugs Market Size (Million USD) (2014-2025) Figure Europe Parkinsons Disease Drugs Market Size (Million USD) (2014-2025) Figure China Parkinsons Disease Drugs Market Size (Million USD) (2014-2025) Figure Japan Parkinsons Disease Drugs Market Size (Million USD) (2014-2025) Figure Southeast Asia Parkinsons Disease Drugs Market Size (Million USD) (2014-2025) Figure India Parkinsons Disease Drugs Market Size (Million USD) (2014-2025) Table Parkinsons Disease Drugs Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Parkinsons Disease Drugs in 2018 Figure Manufacturing Process Analysis of Parkinsons Disease Drugs Figure Industry Chain Structure of Parkinsons Disease Drugs Table Capacity and Commercial Production Date of Key Manufacturers Table Global Parkinsons Disease Drugs Manufacturing Plants Distribution Table Parkinsons Disease Drugs Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Parkinsons Disease Drugs Capacity (Units) of Major Manufacturers (2014-2019) Table Parkinsons Disease Drugs Production (Units) of Major Manufacturers (2014-2019) Table Parkinsons Disease Drugs Production Market Share of Major Manufacturers (2014-2019) Figure Parkinsons Disease Drugs Production Share by Manufacturers in 2018 Table Parkinsons Disease Drugs Revenue (Million US$) of Major Manufacturers (2014-2019) Table Parkinsons Disease Drugs Revenue Market Share of Major Manufacturers (2014-2019) Figure Parkinsons Disease Drugs Revenue Share by Manufacturers in 2018 Table Parkinsons Disease Drugs Average Price (USD/Unit) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Parkinsons Disease Drugs Production by Regions 2014-2019 (Units) Table Global Parkinsons Disease Drugs Production Market Share by Regions 2014-2019 Figure Global Parkinsons Disease Drugs Production Market Share by Regions in 2018 Table Global Parkinsons Disease Drugs Revenue by Regions 2014-2019 (Million USD) Table Global Parkinsons Disease Drugs Revenue Market Share by Regions 2014-2019 Figure Global Parkinsons Disease Drugs Revenue Market Share by Regions in 2018 Table Global Parkinsons Disease Drugs Consumption by Regions 2014-2019 (Units) Table Global Parkinsons Disease Drugs Consumption Market Share by Regions 2014-2019 Figure North America Parkinsons Disease Drugs Production Growth Rate 2014-2019 (Units) Figure North America Parkinsons Disease Drugs Revenue Growth Rate 2014-2019 (Million USD) Table North America Parkinsons Disease Drugs Production, Consumption Import and Export (Units) Figure Europe Parkinsons Disease Drugs Production Growth Rate 2014-2019 (Units) Figure Europe Parkinsons Disease Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Europe Parkinsons Disease Drugs Production, Consumption Import and Export (Units) Figure China Parkinsons Disease Drugs Production Growth Rate 2014-2019 (Units) Figure China Parkinsons Disease Drugs Revenue Growth Rate 2014-2019 (Million USD) Table China Parkinsons Disease Drugs Production, Consumption Import and Export (Units) Figure Japan Parkinsons Disease Drugs Production Growth Rate 2014-2019 (Units) Figure Japan Parkinsons Disease Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Japan Parkinsons Disease Drugs Production, Consumption Import and Export (Units) Figure Southeast Asia Parkinsons Disease Drugs Production Growth Rate 2014-2019 (Units) Figure Southeast Asia Parkinsons Disease Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Parkinsons Disease Drugs Production, Consumption Import and Export (Units) Figure India Parkinsons Disease Drugs Production Growth Rate 2014-2019 (Units) Figure India Parkinsons Disease Drugs Revenue Growth Rate 2014-2019 (Million USD) Table India Parkinsons Disease Drugs Production, Consumption Import and Export (Units) Figure Global Consumption Parkinsons Disease Drugs Market Share by Application (2014-2019) Figure Global Value (Consumption) Parkinsons Disease Drugs Market Share by Application (2014-2019) Table Johnson & Johnson Parkinsons Disease Drugs Production Sites and Area Served Table Johnson & Johnson Parkinsons Disease Drugs Product Introduction, Application and Specification Table Johnson & Johnson Parkinsons Disease Drugs Production (Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Johnson & Johnson Parkinsons Disease Drugs Production Growth Rate (2014-2019) Table Johnson & Johnson Parkinsons Disease Drugs Production Market Share (2014-2019) Figure Johnson & Johnson Parkinsons Disease Drugs Revenue Market Share (2014-2019) Table Johnson & Johnson Parkinsons Disease Drugs Main Business and Markets Served Table Gilead Sciences Parkinsons Disease Drugs Production Sites and Area Served Table Gilead Sciences Parkinsons Disease Drugs Product Introduction, Application and Specification Table Gilead Sciences Parkinsons Disease Drugs Production (Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Gilead Sciences Parkinsons Disease Drugs Production Growth Rate (2014-2019) Table Gilead Sciences Parkinsons Disease Drugs Production Market Share (2014-2019) Figure Gilead Sciences Parkinsons Disease Drugs Revenue Market Share (2014-2019) Table Gilead Sciences Parkinsons Disease Drugs Main Business and Markets Served Table Pacira Parkinsons Disease Drugs Production Sites and Area Served Table Pacira Parkinsons Disease Drugs Product Introduction, Application and Specification Table Pacira Parkinsons Disease Drugs Production (Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Pacira Parkinsons Disease Drugs Production Growth Rate (2014-2019) Table Pacira Parkinsons Disease Drugs Production Market Share (2014-2019) Figure Pacira Parkinsons Disease Drugs Revenue Market Share (2014-2019) Table Pacira Parkinsons Disease Drugs Main Business and Markets Served Table Sun Pharmaceutical Parkinsons Disease Drugs Production Sites and Area Served Table Sun Pharmaceutical Parkinsons Disease Drugs Product Introduction, Application and Specification Table Sun Pharmaceutical Parkinsons Disease Drugs Production (Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Sun Pharmaceutical Parkinsons Disease Drugs Production Growth Rate (2014-2019) Table Sun Pharmaceutical Parkinsons Disease Drugs Production Market Share (2014-2019) Figure Sun Pharmaceutical Parkinsons Disease Drugs Revenue Market Share (2014-2019) Table Sun Pharmaceutical Parkinsons Disease Drugs Main Business and Markets Served Table Luye Pharma Parkinsons Disease Drugs Production Sites and Area Served Table Luye Pharma Parkinsons Disease Drugs Product Introduction, Application and Specification Table Luye Pharma Parkinsons Disease Drugs Production (Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Luye Pharma Parkinsons Disease Drugs Production Growth Rate (2014-2019) Table Luye Pharma Parkinsons Disease Drugs Production Market Share (2014-2019) Figure Luye Pharma Parkinsons Disease Drugs Revenue Market Share (2014-2019) Table Luye Pharma Parkinsons Disease Drugs Main Business and Markets Served Table Sigma-Tau Group Parkinsons Disease Drugs Production Sites and Area Served Table Sigma-Tau Group Parkinsons Disease Drugs Product Introduction, Application and Specification Table Sigma-Tau Group Parkinsons Disease Drugs Production (Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Sigma-Tau Group Parkinsons Disease Drugs Production Growth Rate (2014-2019) Table Sigma-Tau Group Parkinsons Disease Drugs Production Market Share (2014-2019) Figure Sigma-Tau Group Parkinsons Disease Drugs Revenue Market Share (2014-2019) Table Sigma-Tau Group Parkinsons Disease Drugs Main Business and Markets Served Table Fudan-Zhangjiang Parkinsons Disease Drugs Production Sites and Area Served Table Fudan-Zhangjiang Parkinsons Disease Drugs Product Introduction, Application and Specification Table Fudan-Zhangjiang Parkinsons Disease Drugs Production (Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Fudan-Zhangjiang Parkinsons Disease Drugs Production Growth Rate (2014-2019) Table Fudan-Zhangjiang Parkinsons Disease Drugs Production Market Share (2014-2019) Figure Fudan-Zhangjiang Parkinsons Disease Drugs Revenue Market Share (2014-2019) Table Fudan-Zhangjiang Parkinsons Disease Drugs Main Business and Markets Served Table Teva Pharmaceutical Parkinsons Disease Drugs Production Sites and Area Served Table Teva Pharmaceutical Parkinsons Disease Drugs Product Introduction, Application and Specification Table Teva Pharmaceutical Parkinsons Disease Drugs Production (Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Teva Pharmaceutical Parkinsons Disease Drugs Production Growth Rate (2014-2019) Table Teva Pharmaceutical Parkinsons Disease Drugs Production Market Share (2014-2019) Figure Teva Pharmaceutical Parkinsons Disease Drugs Revenue Market Share (2014-2019) Table Teva Pharmaceutical Parkinsons Disease Drugs Main Business and Markets Served Table CSPC Parkinsons Disease Drugs Production Sites and Area Served Table CSPC Parkinsons Disease Drugs Product Introduction, Application and Specification Table CSPC Parkinsons Disease Drugs Production (Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table CSPC Parkinsons Disease Drugs Production Growth Rate (2014-2019) Table CSPC Parkinsons Disease Drugs Production Market Share (2014-2019) Figure CSPC Parkinsons Disease Drugs Revenue Market Share (2014-2019) Table CSPC Parkinsons Disease Drugs Main Business and Markets Served Table Novartis Parkinsons Disease Drugs Production Sites and Area Served Table Novartis Parkinsons Disease Drugs Product Introduction, Application and Specification Table Novartis Parkinsons Disease Drugs Production (Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis Parkinsons Disease Drugs Production Growth Rate (2014-2019) Table Novartis Parkinsons Disease Drugs Production Market Share (2014-2019) Figure Novartis Parkinsons Disease Drugs Revenue Market Share (2014-2019) Table Novartis Parkinsons Disease Drugs Main Business and Markets Served Table Kingond Pharm Parkinsons Disease Drugs Production Sites and Area Served Figure Global Parkinsons Disease Drugs Production (Units) Growth Rate Forecast 2019-2025 Figure Global Parkinsons Disease Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Parkinsons Disease Drugs Sales Price (USD/Unit) Forecast 2019-2025 Figure North America Parkinsons Disease Drugs Production Growth Rate Forecast 2019-2025 (Units) Figure North America Parkinsons Disease Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Parkinsons Disease Drugs Production Growth Rate Forecast 2019-2025 (Units) Figure Europe Parkinsons Disease Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Parkinsons Disease Drugs Production Growth Rate Forecast 2019-2025 (Units) Figure China Parkinsons Disease Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Parkinsons Disease Drugs Production Growth Rate Forecast 2019-2025 (Units) Figure Japan Parkinsons Disease Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Parkinsons Disease Drugs Production Growth Rate Forecast 2019-2025 (Units) Figure Southeast Asia Parkinsons Disease Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Parkinsons Disease Drugs Production Growth Rate Forecast 2019-2025 (Units) Figure India Parkinsons Disease Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (Units) of Parkinsons Disease Drugs by Type (2019-2025) Table Global Consumption (Units) of Parkinsons Disease Drugs by Application (2019-2025) Table Parkinsons Disease Drugs Distributors List Table Parkinsons Disease Drugs Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Johnson & Johnson Gilead Sciences Pacira Sun Pharmaceutical Luye Pharma Sigma-Tau Group Fudan-Zhangjiang Teva Pharmaceutical CSPC Novartis Kingond Pharm